RT Journal Article
SR Electronic
T1 How are sociodemographic factors and risk preferences associated with seasonal influenza vaccination behavior under the COVID-19 pandemic?
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.04.30.21256364
DO 10.1101/2021.04.30.21256364
A1 Mori, Takahiro
A1 Nagata, Tomohisa
A1 Ikegami, Kazunori
A1 Hino, Ayako
A1 Tateishi, Seiichiro
A1 Tsuji, Mayumi
A1 Matsuda, Shinya
A1 Fujino, Yoshihisa
A1 Mori, Koji
A1 ,
YR 2021
UL http://medrxiv.org/content/early/2021/05/03/2021.04.30.21256364.abstract
AB Background Vaccine hesitancy is an issue for vaccines required for herd immunity. Although various factors such as sociodemographics can affect vaccine hesitancy, the research results differ and it is unclear whether these differences depend on the subjects or the situation, such as the type of infection or vaccine. Therefore, we investigated the relationship between seasonal influenza vaccination behavior and sociodemographic factors under the COVID-19 pandemic. In addition, we analyzed the relationship between individual factors of risk preference and seasonal influenza vaccination on the premise that there is a difference in the association between efficacy and the risk of side effects of the two vaccines.Methods A cross-sectional study was conducted on workers aged 20–65 years on December 22–25, 2020, using data from an Internet survey. We set the presence or absence of 2020/2021 seasonal influenza vaccination as the dependent variable, and each aspect of sociodemographic factors and risk preference as independent variables. We performed a multilevel logistic regression analysis nested by residence.Results In total, 26,637 respondents (13,600 men, 13,037 women) participated. Significantly more women than men were vaccinated. Both men and women had higher vaccination rates if married, highly educated, with high income, and with underlying disease. Men aged 60–65 had a significantly higher vaccination rate than those aged 20–29, while women aged 40–49 and 50–59 had a significantly lower rate than those aged 20–29. These results differed from those of a previous study on the vaccination intentions of the same subjects for COVID-19. Those with low risk preference had higher vaccination rates than those with high risk preference.Conclusions Our results suggested that the effect of sociodemographic factors on vaccine hesitancy depends on the situation affecting efficacy of the vaccine and the perception of vaccination risk.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was funded by a research grant from the University of Occupational and Environmental Health, Japan; a general incorporated foundation (Anshin Zaidan) for the development of educational materials on mental health measures for managers at small-sized enterprises; Health, Labour and Welfare Sciences Research Grants: Comprehensive Research for Women's Healthcare (H30-josei-ippan-002) and Research for the establishment of an occupational health system in times of disaster (H30-roudou-ippan-007); consigned research foundation (the Collabo-health Study Group); and scholarship donations from Chugai Pharmaceutical Co., Ltd.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was approved by the Ethics Committee of the University of Occupational and Environmental Health, Kitakyushu, Japan (Approval No. R2-079)All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data that support the findings of this study are available from the corresponding author,TM, upon reasonable request.